Cigna Group $CI Shares Acquired by Hohimer Wealth Management LLC

Posted by George Bondi on Nov 9th, 2026

Hohimer Wealth Management LLC lifted its stake in Cigna Group (NYSE:CI – Free Report) by 18.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,408 shares of the health services provider’s stock after buying an additional 3,119 shares during the period. Hohimer Wealth Management LLC’s holdings in Cigna Group were worth $5,548,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CI. Osbon Capital Management LLC bought a new position in Cigna Group during the second quarter valued at about $26,000. Putney Financial Group LLC bought a new stake in shares of Cigna Group in the 3rd quarter worth approximately $27,000. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Fiduciary Financial Advisors acquired a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Finally, Cedar Mountain Advisors LLC increased its position in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Up 0.0%

NYSE CI opened at $293.66 on Monday. Cigna Group has a 1-year low of $255.53 and a 1-year high of $318.05. The company has a market capitalization of $77.60 billion, a price-to-earnings ratio of 12.96, a PEG ratio of 1.01 and a beta of 0.25. The stock’s 50 day moving average is $285.81 and its two-hundred day moving average is $282.17. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66.

Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. The business had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. Cigna Group’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.83 EPS. Equities analysts forecast that Cigna Group will post 30.62 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio is currently 27.54%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Royal Bank Of Canada restated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research note on Thursday, October 1st. Guggenheim decreased their price target on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research note on Friday. UBS Group reissued a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Evercore assumed coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective for the company. Finally, Barclays increased their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fourteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $335.70.

View Our Latest Stock Report on Cigna Group

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Cigna Group Company Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.